TransCode Therapeutics (RNAZ) Short Interest Ratio & Short Volume

$0.30

-0.01 (-3.27%)

(As of 07/26/2024 ET)

Compare

TransCode Therapeutics Short Interest Data

Current Short Interest: 24,700 shares
Previous Short Interest: 167,200 shares
Change Vs. Previous Month: -85.23%
Dollar Volume Sold Short: $22,237.41
Short Interest Ratio: 0.0 Days to Cover
Last Record Date: July 15, 2024

Outstanding Shares: 6,622,000 shares
Float Size: 6,590,000 shares
Short Percent of Float: 0.37%
Today's Trading Volume: 7,272,034 shares
Average Trading Volume: 1,020,678 shares
Today's Volume Vs. Average: 712%

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Short Selling TransCode Therapeutics ?

Sign up to receive the latest short interest report for TransCode Therapeutics and its competitors with MarketBeat's FREE newsletter.

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

RNAZ Short Interest Over Time

RNAZ Days to Cover Over Time

RNAZ Percentage of Float Shorted Over Time

Ad Crypto Swap Profits

625,000% Gain

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

TransCode Therapeutics Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
7/15/2024	24,700 shares	$22,237.41	-85.2%	0.4%	0	$0.90
6/30/2024	167,200 shares	$168,036.00	-62.7%	2.5%	0.1	$1.01
6/15/2024	448,500 shares	$538,200.00	-56.0%	6.9%	0.4	$1.20
5/31/2024	1,020,000 shares	$1.81 million	+486.5%	15.6%	0.8	$1.78
5/15/2024	173,900 shares	$140,267.74	+16.2%	2.7%	0.1	$0.81
4/30/2024	149,600 shares	$90,822.16	+704.3%	2.3%	0.2	$0.61
Get the Latest News and Ratings for RNAZ and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
4/15/2024	18,600 shares	$9,975.18	-53.5%	0.3%	0	$0.54
3/31/2024	40,000 shares	$27,320.00	-77.1%	0.6%	0.1	$0.68
3/15/2024	174,800 shares	$120,786.80	+71.4%	2.7%	0.3	$0.69
2/29/2024	102,000 shares	$71,869.20	-53.8%	1.6%	0.2	$0.70
2/15/2024	220,900 shares	$145,794.00	-70.8%	3.4%	0.4	$0.66
1/31/2024	755,300 shares	$521,912.30	+7,529.3%	13.0%	1.6	$0.69
1/15/2024	9,900 shares	$49,500.00	-97.6%	1.8%	0	$5.00
12/31/2023	405,000 shares	$66,744.00	-7.4%	N/A	0.1	$0.16
12/15/2023	437,500 shares	$74,156.25	-31.3%	2.0%	0.1	$0.17
11/30/2023	637,200 shares	$156,751.20	+31.8%	3.0%	0.1	$0.25
11/15/2023	483,300 shares	$138,610.44	-63.4%	2.5%	0.1	$0.29
10/31/2023	1,320,000 shares	$488,664.00	+562.0%	7.4%	0.2	$0.37
10/15/2023	199,400 shares	$86,100.92	+173.9%	6.2%	0	$0.43
9/30/2023	72,800 shares	$36,596.56	-42.4%	4.5%	0	$0.50
9/15/2023	126,400 shares	$84,511.04	+418.0%	7.1%	0.1	$0.67
8/31/2023	24,400 shares	$35,380.00	+1,255.6%	1.7%	0.2	$1.45
8/15/2023	1,800 shares	$2,916.00	-87.8%	0.1%	0	$1.62
7/31/2023	14,700 shares	$32,340.00	-85.5%	2.5%	0.1	$2.20
7/15/2023	101,500 shares	$257,810.00	+81.9%	16.9%	0.4	$2.54
6/30/2023	55,800 shares	$128,340.00	+14.6%	9.3%	0.2	$2.30
6/15/2023	48,700 shares	$129,055.00	+79.7%	8.1%	0.2	$2.65
5/31/2023	27,100 shares	$113,820.00	+22.1%	4.4%	0.2	$4.20
5/15/2023	22,200 shares	$135,109.20	-96.6%	N/A	0.5	$6.09
4/30/2023	653,200 shares	$206,345.88	+2.7%	5.6%	0.4	$0.32
4/15/2023	636,000 shares	$250,965.60	+99.5%	5.5%	0.4	$0.39
3/31/2023	318,800 shares	$107,913.80	+21.0%	2.8%	0.2	$0.34
3/15/2023	263,500 shares	$91,618.95	-51.3%	2.3%	0.2	$0.35
2/28/2023	541,400 shares	$282,069.40	-42.9%	4.7%	0.1	$0.52
2/15/2023	948,400 shares	$635,428.00	+104.5%	7.5%	0.2	$0.67
1/31/2023	463,700 shares	$348,145.96	+0.8%	5.3%	0.2	$0.75
1/15/2023	459,900 shares	$281,458.80	-43.5%	5.3%	0.1	$0.61
12/30/2022	814,100 shares	$547,889.30	-22.5%	9.4%	0.3	$0.67
12/15/2022	1,050,000 shares	$472,290.00	+2,849.4%	12.1%	0.4	$0.45
11/30/2022	35,600 shares	$14,240.00	+368.4%	0.4%	0	$0.40
Prepare for a Recession Unlike Any Other (Ad) Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW. GET THE FREE GUIDE
11/15/2022	7,600 shares	$4,164.80	-96.5%	0.1%	0	$0.55
10/31/2022	218,800 shares	$147,033.60	+478.8%	2.5%	0.3	$0.67
10/15/2022	37,800 shares	$41,995.80	-2.1%	0.4%	1.9	$1.11
9/30/2022	38,600 shares	$42,460.00	+565.5%	0.4%	1.9	$1.10
9/15/2022	5,800 shares	$6,728.00	-29.3%	0.1%	0.3	$1.16
8/31/2022	8,200 shares	$9,840.00	+90.7%	0.1%	0.2	$1.20
8/15/2022	4,300 shares	$5,547.00	-66.4%	0.1%	0.1	$1.29
7/31/2022	12,800 shares	$18,176.00	+1.6%	0.2%	0.3	$1.42
7/15/2022	12,600 shares	$16,632.00	+26.0%	0.1%	0.3	$1.32
6/30/2022	10,000 shares	$12,600.00	+1.0%	0.1%	0.2	$1.26
6/15/2022	9,900 shares	$12,573.00	-52.9%	0.1%	0.3	$1.27
5/31/2022	21,000 shares	$38,640.00	-15.7%	0.2%	1.1	$1.84
5/15/2022	24,900 shares	$56,025.00	-46.6%	0.3%	1.5	$2.25
4/30/2022	46,600 shares	$127,218.00	+88.7%	0.5%	2.9	$2.73
4/15/2022	24,700 shares	$70,814.90	-44.9%	0.3%	1.4	$2.87
3/31/2022	44,800 shares	$129,024.00	+37.9%	0.5%	2	$2.88
3/15/2022	32,500 shares	$70,200.00	-38.2%	0.4%	0.9	$2.16
2/28/2022	52,600 shares	$112,038.00	-37.8%	0.7%	1.3	$2.13
2/15/2022	84,600 shares	$181,044.00	-12.6%	1.2%	1.6	$2.14
1/31/2022	96,800 shares	$222,640.00	-24.7%	1.4%	1.6	$2.30
1/15/2022	128,500 shares	$322,535.00	+51.4%	1.8%	1.6	$2.51
12/31/2021	84,900 shares	$215,646.00	+0.7%	1.2%	0.7	$2.54
12/15/2021	84,300 shares	$207,378.00	+157.0%	1.2%	0.3	$2.46
11/30/2021	32,800 shares	$90,200.00	+32.8%	0.5%	0	$2.75
11/15/2021	24,700 shares	$73,606.00	-86.7%	0.4%	0	$2.98
10/29/2021	185,900 shares	$526,097.00	-22.9%	2.6%	0	$2.83
10/15/2021	241,100 shares	$776,342.00	-47.1%	3.4%	0.1	$3.22
9/30/2021	455,400 shares	$1.36 million	+1,350.3%	6.4%	0.1	$2.99
9/15/2021	31,400 shares	$81,012.00	-39.7%	0.4%	0	$2.58
8/31/2021	52,100 shares	$158,384.00	+128.5%	0.7%	0	$3.04
8/13/2021	22,800 shares	$65,436.00	No Change	0.4%	0	$2.87

RNAZ Short Interest - Frequently Asked Questions

What is TransCode Therapeutics' current short interest?: Short interest is the volume of TransCode Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 24,700 shares of RNAZ short. 0.37% of TransCode Therapeutics' shares are currently sold short. Learn More on TransCode Therapeutics' current short interest.
What is a good short interest percentage for TransCode Therapeutics?: Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.37% of TransCode Therapeutics' floating shares are currently sold short.
Is TransCode Therapeutics' short interest increasing or decreasing?: TransCode Therapeutics saw a drop in short interest in the month of July. As of July 15th, there was short interest totaling 24,700 shares, a drop of 85.2% from the previous total of 167,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
What is TransCode Therapeutics' float size?: TransCode Therapeutics currently has issued a total of 6,620,000 shares. Some of TransCode Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TransCode Therapeutics currently has a public float of 6,590,000 shares.

How does TransCode Therapeutics' short interest compare to its competitors?: 0.37% of TransCode Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to TransCode Therapeutics: Sunshine Biopharma, Inc. (1.54%), Alterity Therapeutics Limited (0.21%), Shuttle Pharmaceuticals Holdings, Inc. (0.80%), TC Biopharm (Holdings) Plc (0.39%), Bionomics Limited (1.82%), GeoVax Labs, Inc. (5.29%), Alaunos Therapeutics, Inc. (9.66%), IM Cannabis Corp. (3.12%), Lixte Biotechnology Holdings, Inc. (0.67%), Hoth Therapeutics, Inc. (1.07%),
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.
What does it mean to sell short TransCode Therapeutics stock?: Short selling RNAZ is an investing strategy that aims to generate trading profit from TransCode Therapeutics as its price is falling. RNAZ shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against TransCode Therapeutics?: A short squeeze for TransCode Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RNAZ, which in turn drives the price of the stock up even further.
How often is TransCode Therapeutics' short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RNAZ, twice per month. The most recent reporting period available is July, 15 2024.